01/16/2015 - 1:30pm

AbbVie announced that the Food and Drug Administration has approved its Duopa (carbidopa and levodopa) enteral suspension, which is used to treat motor fluctuations for people with advanced Parkinson's disease. 

 

01/16/2015 - 11:20am

A report published in the Jan. 16 Morbidity and Mortality Weekly Report estimates that getting a flu vaccine this season reduced a person’s risk of having to go to the doctor because of flu by 23% among people of all ages.

01/16/2015 - 11:05am

Kathleen "Cook" Uhl on Thursday was named director of the Food and Drug Administration's Office of Generic Drugs.

 

01/14/2015 - 1:20pm

The Food and Drug Administration established the Office of Pharmaceutical Quality, a new division tasked with improving quality control at pharmaceutical manufacturing facilities.

 

01/13/2015 - 5:12pm

NACDS president and CEO Steve Anderson released a statement highlighting the important role that pharmacists play and praised the increased recognition by lawmakers and the nation’s governors.

 

01/12/2015 - 2:34pm

Halfway through the 2014-15 flu season, the Centers for Disease Control and Prevention reported that antiviral medications are being underutilized. 

01/12/2015 - 9:13am

The Council for Responsible Nutrition Foundation on Monday announced it has pledged additional grants — now totaling more than $2.1 million — to the National Advertising Division.

01/09/2015 - 12:58pm

Daiichi Sankyo Co., Limited on Friday announced that the Food and Drug Administration has approved Savaysa (edoxaban) tablets, an oral, once-daily selective factor Xa-inhibitor that reduces the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation. 

 

01/08/2015 - 1:31pm

Camber Pharmaceuticals on Thursday announced the launch of valsartan tablets USP in 40-, 80-, 106- and 320-mg dosage strengths.